- Previous Close
574.73 - Open
576.14 - Bid 579.96 x 800
- Ask 580.65 x 800
- Day's Range
572.13 - 588.62 - 52 Week Range
415.60 - 603.82 - Volume
450,636 - Avg. Volume
1,513,211 - Market Cap (intraday)
224.491B - Beta (5Y Monthly) 0.77
- PE Ratio (TTM)
36.55 - EPS (TTM)
16.09 - Earnings Date Oct 7, 2024 - Oct 11, 2024
- Forward Dividend & Yield 1.56 (0.27%)
- Ex-Dividend Date Sep 13, 2024
- 1y Target Est
628.71
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
www.thermofisher.com122,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TMO
View More
Performance Overview: TMO
Trailing total returns as of 7/25/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMO
View MoreValuation Measures
Market Cap
219.38B
Enterprise Value
245.97B
Trailing P/E
35.65
Forward P/E
26.53
PEG Ratio (5yr expected)
2.31
Price/Sales (ttm)
5.23
Price/Book (mrq)
4.63
Enterprise Value/Revenue
5.81
Enterprise Value/EBITDA
21.13
Financial Highlights
Profitability and Income Statement
Profit Margin
14.69%
Return on Assets (ttm)
4.85%
Return on Equity (ttm)
13.53%
Revenue (ttm)
42.35B
Net Income Avi to Common (ttm)
6.22B
Diluted EPS (ttm)
16.09
Balance Sheet and Cash Flow
Total Cash (mrq)
8.82B
Total Debt/Equity (mrq)
74.48%
Levered Free Cash Flow (ttm)
6.52B
Research Analysis: TMO
View MoreCompany Insights: TMO
TMO does not have Company Insights
Research Reports: TMO
View MoreThermo Fisher Earnings: More of the Same, Second Half Should Return to Growth
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
RatingPrice TargetWhile Thermo Fisher's Near-Term Environment Is Constrained, Long-Term Prospects Are Strong
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
RatingPrice TargetLifting EPS estimates on upbeat outlook
Thermo Fisher manufactures scientific instruments, consumables, and chemicals. It provides analytical instruments, lab equipment, software reagents, and supplies to pharmaceutical companies, hospitals, clinical diagnostic labs, universities, research institutions, and government agencies.
RatingPrice TargetU.S. stocks have been all over the place on Friday morning, as futures
U.S. stocks have been all over the place on Friday morning, as futures suggested a down day ahead of the release of the latest PCE; futures then turned higher after the release and indeed stocks opened broadly higher; and then enthusiasm cooled quickly. As of midday, the S&P 500, Nasdaq Composite and Russell 2000 are lower, with the DJIA clinging to a modest gain. In other areas, crude, gold, and Bitcoin are all lower. As things stand, it looks like May will end an otherwise solid month with a dud in the final week.